Mviyes Pharma Ventures Private Limited, a amalgamated private limited company, was established on 30 March 2017 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999TG2017PTC116265. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹150.25 Cr and a paid-up capital of ₹150.25 Cr.
It upholds a compliant status. Its leadership includes Thomas Koshy Vellutheril (Cfo), Sapna (Director), Madadi Venkat Reddy (Whole-Time Director). Past directors included Nagesh Kumar Middey, Vivek Kaushik, Chunduru Nagendram Maruti. It holds no open charges and ₹675.00 Cr settled loans. Its latest AGM occurred on 19 June 2023, with the balance sheet filed on 31 March 2023. It is based at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
U74999TG2017PTC116265
116265
30 March 2017
₹150.25 Cr
₹150.25 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Mviyes Pharma Ventures Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Thomas Koshy Vellutheril | Cfo | 01 Jul 2021 | Current |
| Sapna | Director | 23 Oct 2020 | Current |
| Madadi Venkat Reddy | Whole-Time Director | 01 Jul 2021 | Current |
| Suryanarayana Murthy Mula | Director | 23 Oct 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 23 Oct 2020 | Past |
| Pramod Abcsdd | Director | 31 Oct 2018 | Past |
| Pramod Abcsdd | Additional Director | 09 Nov 2018 | Past |
| Pramod Abcsdd | Company Secretary | 08 May 2020 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2021 | Past |
| Pramod Abcsdd | Additional Director | 24 Aug 2021 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Mviyes Pharma Ventures Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 477.34% increase. The company also saw a substantial improvement in profitability, with a 700.75% increase in profit. The company's net worth moved up by a moderate rise of 0.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2022, Mviyes Pharma Ventures had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹6,750,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2019 | Others | ₹675.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Mviyes Pharma Ventures, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mviyes Pharma Ventures, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mviyes Pharma Ventures's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Mviyes Pharma Ventures Private Limited last Annual general meeting of members was held on 19 Jun 2023 as per latest MCA records. was documented.
Progress on Mviyes Pharma Ventures Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Hyderabad. was documented.
Kadapa Gandla Sunanda was appointed as a Company Secretary was appointed as a Company Secretary on 04 Nov 2022 & has been associated with this company since 3 years 27 days . was recorded as a recent event.
The activity A charge registered on 27 Sep 2019 via Charge ID 100295902 with Others was fully satisfied on 23 Aug 2021. was completed.
The activity Thomas Koshy Vellutheril was appointed as a CFO was appointed as a CFO on 01 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
The activity Thomas Koshy was appointed as a CFO was appointed as a CFO on 01 Jul 2021 & has been associated with this company since 4 years 5 months . was completed.
The CIN of Mviyes Pharma Ventures Private Limited is U74999TG2017PTC116265.
Mviyes Pharma Ventures Private Limited is headquartered at Galaxy, Floors 22-24, Plot No. 1, Survey No. 83/1 Hyderabad Knowledge City, Raidurg Panmak, Tha, Hyderabad, Telangana, 500032.
Mviyes Pharma Ventures Private Limited was incorporated on 30 March 2017.
The current directors of Mviyes Pharma Ventures Private Limited are
The primary industry of Mviyes Pharma Ventures Private Limited is Manufacturing.
Mviyes Pharma Ventures Private Limited is unlisted.
The authorized capital of Mviyes Pharma Ventures Private Limited is ₹150.25 Cr, and the paid-up capital is ₹150.25 Cr.
The compliance status of Mviyes Pharma Ventures Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX